Status:
RECRUITING
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Anatomic Stage 0 Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This clinical trial studies the effect of a culturally based brief expressive writing intervention in improving the health of Chinese immigrant stage 0-III breast cancer survivors. Culturally based br...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the health benefits of expressive writing compared with the control condition. II. To characterize how acculturation moderates the effects of expressive writing i...
Eligibility Criteria
Inclusion
- Being diagnosed with stage 0-III breast cancer.
- Completed primary treatment, including surgery, chemotherapy, radiation therapy, immune therapy, and/or targeted therapy within the preceding 5 years.
- Foreign-born Chinese women (aged 18 and older) who lived in the U.S. for at least six months in the past.
Exclusion
- 1\. Exclusion criteria include inability to provide informed consent
Key Trial Info
Start Date :
July 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
285 Patients enrolled
Trial Details
Trial ID
NCT04754412
Start Date
July 23 2021
End Date
April 1 2026
Last Update
May 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030